Background Anti-fibrotic drugs may interfere with wound-healing after major surgery, theoretically
preventing sufficient bronchial anastomosis formation after lung transplantation (LTx). …

Background Fibrotic interstitial lung disease (ILD) is often associated with poor outcomes,
but has few predictors of progression. Daily home spirometry has been proposed to provide …

Background. Cytomegalovirus (CMV)-infection remains a major cause of morbidity and
mortality after lung transplantation. Treatment with currently available drugs poses treatment …

Identification of disease phenotypes might improve the understanding of patients with
chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of …

Background In recent years, structured reporting has been shown to be beneficial with regard
to report completeness and clinical decision-making as compared to free-text reports (FTR)…

Objectives To define predictive parameters of long progression-free survival (PFS) in patients
undergoing radioembolisation of neuroendocrine liver metastases. Methods The following …

Purpose To evaluate the diagnostic accuracy of dynamic‐contrast–enhanced (DCE) MRI in
comparison to both 18 F‐FDG‐ and 68 Ga‐DOTATATE‐PET/CT in patients with liver …

Background: This study compared therapeutic azole plasma trough levels (APL) of the
azole antimycotics itraconazole (ITR), voriconazole (VOR), and posaconazole (POS) in lung …

Pirfenidone demonstrated pleiotropic antiinflammatory effects in various experimental and
clinical settings. The aim of this study was to assess the impact of previous treatment with …

Posaconazole is an extended‐spectrum triazole antifungal used in the treatment and
prophylaxis of Aspergillus infections. It is available as oral suspension (POS‐Liq) and delayed‐…